Overview

Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Open-label Study to Investigate the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents.
Phase:
Phase 1
Details
Lead Sponsor:
Vanda Pharmaceuticals